CD8-specific capture agents, compositions, and methods of using and making
Summary
The USPTO granted Regeneron Pharmaceuticals patent US12594350B2 covering stable peptide-based CD8 capture agents for use as detection agents. The patent was issued April 7, 2026, naming Regeneron Pharmaceuticals, Inc. as assignee and Heather Dawn Agnew and Bert Tsunyin Lai as inventors. The application, filed April 4, 2017 (Application No. 15478596), contains 13 claims.
What changed
The USPTO issued patent US12594350B2 to Regeneron Pharmaceuticals on April 7, 2026, covering CD8-specific peptide capture agents, compositions, and methods of using and making them for detection applications. The patent contains 13 claims and was filed under Application No. 15478596. The invention relates to stable peptide-based CD8 capture agents and methods of manufacturing for use as detection agents.
Pharmaceutical and biotechnology companies developing CD8 detection assays, related diagnostic products, or therapeutic applications involving CD8 proteins should evaluate potential freedom-to-operate implications. This patent grant does not impose compliance deadlines or reporting requirements but establishes enforceable intellectual property rights that may affect R&D activities in this space.
Archived snapshot
Apr 7, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
CD8-specific capture agents, compositions, and methods of using and making
Grant US12594350B2 Kind: B2 Apr 07, 2026
Assignee
Regeneron Pharmaceuticals, Inc.
Inventors
Heather Dawn Agnew, Bert Tsunyin Lai
Abstract
The present application provides stable peptide-based CD8 capture agents and methods of use as detection agents. The application further provides methods of manufacturing CD8 capture agents.
CPC Classifications
A61K 51/08 C07K 7/06 C07K 14/001 C07K 14/70517 G01N 33/534 G01N 33/56792 G01N 33/68 G01N 2333/70517 G01N 33/56972
Filing Date
2017-04-04
Application No.
15478596
Claims
13
Named provisions
Related changes
Get daily alerts for USPTO Patent Grants - Peptides (C07K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Grants - Peptides (C07K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.